ChenGuang Biotech Group Co., Ltd. commences an Equity Buyback Plan for CNY 100 million worth of its shares, under the authorization approved on November 17, 2023.

ChenGuang Biotech Group Co., Ltd. (SZSE:300138) commences share repurchases on November 20, 2023, under the program mandated by the shareholders in the Extraordinary General Meeting held on November 17, 2023. As per the mandate, the company is authorized to repurchase not more than CNY 100 million worth of its shares. The shares will be repurchased at a price of CNY 16.5 per share.

The repurchased shares will be cancelled. The company plans to use its own funds for the program. The program will run over a period of 12 months from the date of shareholders' approval.